DE4309288A1 - Pharmaceutical speciality for appetite suppression and digestion promotion in fasting treatments - Google Patents

Pharmaceutical speciality for appetite suppression and digestion promotion in fasting treatments

Info

Publication number
DE4309288A1
DE4309288A1 DE19934309288 DE4309288A DE4309288A1 DE 4309288 A1 DE4309288 A1 DE 4309288A1 DE 19934309288 DE19934309288 DE 19934309288 DE 4309288 A DE4309288 A DE 4309288A DE 4309288 A1 DE4309288 A1 DE 4309288A1
Authority
DE
Germany
Prior art keywords
gum arabic
medicinal charcoal
pharmaceutical
appetite suppression
fasting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19934309288
Other languages
German (de)
Inventor
Karl-Heinz Dr Maier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MAIER KARL HEINZ DR
Original Assignee
MAIER KARL HEINZ DR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MAIER KARL HEINZ DR filed Critical MAIER KARL HEINZ DR
Priority to DE19934309288 priority Critical patent/DE4309288A1/en
Publication of DE4309288A1 publication Critical patent/DE4309288A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/44Elemental carbon, e.g. charcoal, carbon black
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/04Sulfur, selenium or tellurium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Pharmaceutical speciality for suppressing the appetite and promoting the digestion: The combination of the active substances sodium sulphate, medicinal charcoal and gum arabic when used in suitable dosage confers on the body a feeling of repletion despite reduced food intake in fasting treatments. This is achieved by the action of the sodium sulphate. The usual side effect of excessively increased bowel peristalsis with diarrhoea is prevented by the simultaneous intake of medicinal charcoal and gum arabic in suitable gelatin capsules. Medicinal charcoal and gum arabic act to inhibit peristalsis.

Description

In den modernen hochtechnisierten Industriestaaten stellt das Übergewicht bei den Menschen ein häufiges Problem sowohl im psychischen wie im physischen Bereich dar. Unzählig sind die entworfenen Diätpläne ebenso wie die verschiedensten Mittel zur Gewichtsreduzierung. Während die Diätpläne und Hungerkuren meist an mangelnder Ausdauer scheitern, zeigen die meisten künstlichen Hilfen wie Appetitzügler in Form von Tropfen oder Pillen gesundheitlich schädliche Nebenwirkungen.In the modern, high-tech industrialized countries, that means Obesity is a common problem in both humans psychic as in the physical realm. There are countless designed diet plans as well as various means of Weight reduction. While the diet plans and starvation diets mostly most artificial ones show failure due to lack of endurance Aids like appetite suppressants in the form of drops or pills harmful side effects.

Im vorliegenden Fall wurde in erster Linie nach Wirkstoff­ komponenten gesucht, die für den Körper keine schädliche Wirkung, sondern eher eine gesundheitlich positive Wirkung haben. Es werden 3 Wirkstoffe separat in ihrer Wirkung dargestellt:In the present case it was primarily based on active ingredient looking for components that are not harmful to the body Effect, but rather a health-positive effect to have. There are 3 active ingredients separately in their effect shown:

1. Natrium sulfuricum oder Glaubersalz1. Sodium sulfuricum or Glauber's salt

Das Glaubersalz ist in der Medizin als salinisches Abführmittel bekannt. Seine Wirkung ist physikalisch. Das Sulfatanion wird im Magen-Darm-Kanal sehr schlecht resorbiert und kann deswegen über dessen gesamte Ausdehnung osmotisch wirksam bleiben. Für die Wirkung als Abführmittel ist das durch die isotonische Flüssigkeit im Darmlumen erzielte Volumen verantwortlich, das durch Dehnungsreiz im Darm die Peristaltik anregt. Gleichzeitig wird durch die Flüssigkeit die Konsistenz des Darminhaltes herabgesetzt.The Glauber's salt is considered saline in medicine Laxatives known. Its effect is physical. The Sulfate anion is very poorly absorbed in the gastrointestinal tract and can therefore be osmotic over its entire extent remain effective. This is for the effect as a laxative  achieved by the isotonic fluid in the intestinal lumen Volume responsible, which is caused by stretching in the intestine Stimulates peristalsis. At the same time, the liquid the consistency of the intestinal contents decreased.

2. Carbo medicinalis2. Carbo medicinalis

Die Carbo medicinalis ist in der Medizin bekannt als Adsorbens. Sie wird therapeutisch verwendet bei Ver­ giftungen als wirksamstes Mittel zur Fixierung des im Magen oder Darm befindlichen Giftes. Durch ihre Adsorbtionskraft wirkt sie peristaltikhemmend.The Carbo medicinalis is known in medicine as Adsorbent. It is used therapeutically by Ver poisoning as the most effective means of fixing the stomach or intestinal poison. Because of their adsorption power it has an anti-peristaltic effect.

3. Gummi arabicum3. Gum arabic

Das Gummi arabicum ist ein Mucilaginosum (schleimhaltige Droge) und wirkt dadurch peristaltikhemmend, daß es die Schleimhautoberfläche mit einer Schutzschicht überzieht und daher chemische Reize herabgemindert werden.The gum arabic is a mucilaginosum (mucilaginous Drug) and has a peristaltic inhibiting effect that it Mucous surface covered with a protective layer and therefore chemical stimuli can be reduced.

Das Ziel der Arzneimittelspezialität ist es, dem Körper ein Völlegefühl bei nur geringer Nahrungsaufnahme zu geben. Dies wird erreicht durch die Kombination der oben beschriebenen Wirkstoffe. Über den Tag verteilte Zufuhr Glaubersalz in geringen Dosen (Tagesgesamtdosis ca. 5 Gramm) erzeugt im Darm ein erhöhtes Volumen an Wasser und damit ein subjektives Völlegefühl. Damit dieses Völlegefühl anhaltend erzeugt wird und der Organismus nicht durch starken Durchfall beeinflußt wird, ist die Einnahme des Glaubersalzes kombiniert mit der Einnahme von Carbo medicinalis und Gummi arabicum, die beide peristaltikhemmend wirken. Somit wird zwar bei geeigneter Dosierung die Darmtätigkeit angeregt, Durchfälle werden jedoch vermieden.The goal of the drug specialty is to give the body a To give a feeling of fullness with little food intake. This is achieved by combining the above Active ingredients. Intake of Glauber's salt distributed throughout the day in low doses (total daily dose about 5 grams) produced in the intestine an increased volume of water and thus a subjective  Feeling of fullness. So that this feeling of fullness is generated and the organism is not affected by severe diarrhea, is the intake of the Glauber's salt combined with the intake of carbo medicinalis and gum arabic, both of which have a peristaltic effect. Thus, if appropriate Dosage stimulates intestinal activity, but diarrhea does avoided.

Das Ziel, dem Körper während einer Fastenkur dennoch ein Völlegefühl zu vermitteln und damit ein vermindert es Hungergefühl zu geben, ist durch die beschriebene Kombination gegeben, ohne daß dem Organismus Schaden zugefügt wird. Als positive Begleiterscheinung ist eine gewisse Entschlackung durch die Bindung von Giftstoffen an die Carbo medicinalis und die beruhigende einschleimende Wirkung des Gummi arabicum auf die Darmschleimhaut. Oft in Begleitung mit Fastenkuren auftretende Darmträgheiten werden ebenso vermieden wie Magendarmentzündungen vorgebeugt wird.The goal is to enter the body during a fasting regimen To convey a feeling of fullness and thus reduce it The combination described describes the feeling of hunger given without causing harm to the organism. When positive side effect is a certain detoxification the binding of toxins to the carbo medicinalis and the soothing effect of gum arabic on the Intestinal mucosa. Often accompanied by fasting cures Intestinal sluggishness is avoided, as is gastrointestinal inflammation is prevented.

Die Verabreichung der Arzneimittelspezialität erfolgt mit Gelatinekapseln. Die Wirkstoffmenge der drei Komponenten verhält sich volumenmäßig etwa 1 : 1 : 1. Die Dosierung liegt bei täglich etwa 3 × 3 bis 6 Gramm. Die Dosis kann bedenkenlos auf das Doppelte erhöht werden.The drug specialty is administered with Gelatin capsules. The amount of active ingredient of the three components behaves volume by about 1: 1: 1. The dosage is included about 3 × 3 to 6 grams daily. The dose can be safely raised be increased twice.

Claims (1)

Arzneimittelspezialität zur Appetithemmung und Förderung der Verdauung bei Fastenkuren, dadurch gekennzeichnet, daß durch die Kombinationsverwendung der 3 Wirkstoffe Natrium sulfuricum, Carbo medicinalis und Gummi Arabicum im Verdauungstrakt durch eine anhaltende, leichte, den Organismus nicht schädigende Blähung ein künstliches Völlegefühl bei gleichzeitig angeregter Verdaungsstätigkeit erzeugt wird.Pharmaceutical specialty to inhibit appetite and promote digestion during fasting cures, characterized in that the combination use of the three active ingredients sodium sulfuricum, carbo medicinalis and gum arabic in the digestive tract creates an artificial feeling of fullness with simultaneous stimulated digestive activity through persistent, light, non-damaging bloating .
DE19934309288 1993-03-23 1993-03-23 Pharmaceutical speciality for appetite suppression and digestion promotion in fasting treatments Withdrawn DE4309288A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19934309288 DE4309288A1 (en) 1993-03-23 1993-03-23 Pharmaceutical speciality for appetite suppression and digestion promotion in fasting treatments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19934309288 DE4309288A1 (en) 1993-03-23 1993-03-23 Pharmaceutical speciality for appetite suppression and digestion promotion in fasting treatments

Publications (1)

Publication Number Publication Date
DE4309288A1 true DE4309288A1 (en) 1994-09-29

Family

ID=6483552

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19934309288 Withdrawn DE4309288A1 (en) 1993-03-23 1993-03-23 Pharmaceutical speciality for appetite suppression and digestion promotion in fasting treatments

Country Status (1)

Country Link
DE (1) DE4309288A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023078802A1 (en) 2021-11-03 2023-05-11 Evonik Operations Gmbh New method for recycling of polyurethane

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023078802A1 (en) 2021-11-03 2023-05-11 Evonik Operations Gmbh New method for recycling of polyurethane

Similar Documents

Publication Publication Date Title
US5707630A (en) Herbal compound for relief of PMS through menopausal symptoms
DE69912434T2 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF FUNCTIONAL DYSPEPSY AND / OR THE IRRIDAL SYNDROME AND THE USE OF NEW SUBSTANCES IN THIS COMPOSITION
CH654745A5 (en) COMPOSITION FOR THE TREATMENT OF ALCOHOLIC AND DRUG ADDICTORS.
DE1902227A1 (en) Medicines for psychotherapeutic use and processes for their manufacture
EP0125634B1 (en) Use of a secretolytically active substance for the manufacture of a remedy against snoring and for combating snore phenomenon
WO2009036906A1 (en) Composition with laxative/antifoam active ingredient combination for the treatment of constipation
EP0219156B1 (en) Appetite moderating and anti-gastritis composition
DE3011437A1 (en) PHARMACEUTICAL AGENT FOR HEALING INFLAMMABLE AND / OR DEGENERATIVE AND / OR ATROPHIC MUSCULAR DISEASES
CN1857458A (en) Health product and medicine and their preparing method
DE4309288A1 (en) Pharmaceutical speciality for appetite suppression and digestion promotion in fasting treatments
DE3642853A1 (en) Pharmaceutical composition
DE102017006532A1 (en) Medicines and drink for the improvement of joint and bone disorders
DE2820899C2 (en)
EP0256353A2 (en) Pharmaceutical therapy against the bad absorption of food or oral drugs
CN1050045C (en) Traditional Chinese medicine-Liu's Hua'ai huixiangdan for treating carcinoma of esophagus
DE2352618B2 (en) PERORALLY OR RECTALLY ADMINISTRATIVE MEDICINE FOR THE TREATMENT OF PARKINSONISM
DE202005000948U1 (en) Composition for the treatment of apnea, snoring and sleep disorders
DE19633446B4 (en) Medicinal products with lipid-lowering action
WO2002069987A2 (en) Agent for treating diabetes mellitus
CN1066956C (en) Weitongxiao traditional Chinese medicine for curing gastro-duodenal ulcer and gastrorrhagia
DE2015877A1 (en) drug
CN1111049C (en) Medicine powder for curing angitis and its preparing method
DE60020888T2 (en) EXTRACTS FROM HERBS FOR THE TREATMENT OF COGNITIVE DISTURBANCES DUE TO ESTROGEN LOSS
DE3317558A1 (en) Oral antisnoring composition
CN1239168C (en) Medicine for treating constipation and preparation method thereof

Legal Events

Date Code Title Description
8122 Nonbinding interest in granting licenses declared
8139 Disposal/non-payment of the annual fee